Randomized phase II neoadjuvant comparison between letrozole, anastrozole, and exemestane for postmenopausal women with estrogen receptor–rich stage 2 to 3 …
Purpose Preoperative aromatase inhibitor (AI) treatment promotes breast-conserving
surgery (BCS) for estrogen receptor (ER)–positive breast cancer. To study this treatment …
surgery (BCS) for estrogen receptor (ER)–positive breast cancer. To study this treatment …
Randomized phase II neoadjuvant comparison between letrozole, anastrozole, and exemestane for postmenopausal women with estrogen receptor-rich stage 2 to 3 …
MJ Ellis, VJ Suman, J Hoog, L Lin, J Snider… - Journal of Clinical …, 2011 - europepmc.org
Purpose Preoperative aromatase inhibitor (AI) treatment promotes breast-conserving
surgery (BCS) for estrogen receptor (ER)-positive breast cancer. To study this treatment …
surgery (BCS) for estrogen receptor (ER)-positive breast cancer. To study this treatment …
Randomized phase II neoadjuvant comparison between letrozole, anastrozole, and exemestane for postmenopausal women with estrogen receptor-rich stage 2 to 3 …
MJ Ellis, VJ Suman, J Hoog… - Journal of …, 2011 - mdanderson.elsevierpure.com
Purpose: Preoperative aromatase inhibitor (AI) treatment promotes breast-conserving
surgery (BCS) for estrogen receptor (ER)-positive breast cancer. To study this treatment …
surgery (BCS) for estrogen receptor (ER)-positive breast cancer. To study this treatment …
[PDF][PDF] Matthew J. Ellis, Vera J. Suman, Jeremy Hoog, Li Lin, Jacqueline Snider, Aleix Prat, Joel S. Parker, Jingqin Luo, Katherine DeSchryver, D. Craig Allred, Laura J …
J Clin Oncol, 2011 - scholar.archive.org
Purpose Preoperative aromatase inhibitor (AI) treatment promotes breast-conserving
surgery (BCS) for estrogen receptor (ER)–positive breast cancer. To study this treatment …
surgery (BCS) for estrogen receptor (ER)–positive breast cancer. To study this treatment …
Randomized phase II neoadjuvant comparison between letrozole, anastrozole, and exemestane for postmenopausal women with estrogen receptor-rich stage 2 to 3 …
MJ Ellis, VJ Suman, J Hoog… - Journal of …, 2011 - utsouthwestern.elsevierpure.com
Purpose: Preoperative aromatase inhibitor (AI) treatment promotes breast-conserving
surgery (BCS) for estrogen receptor (ER)-positive breast cancer. To study this treatment …
surgery (BCS) for estrogen receptor (ER)-positive breast cancer. To study this treatment …
[PDF][PDF] Matthew J. Ellis, Vera J. Suman, Jeremy Hoog, Li Lin, Jacqueline Snider, Aleix Prat, Joel S. Parker, Jingqin Luo, Katherine DeSchryver, D. Craig Allred, Laura J …
J Clin Oncol, 2011 - researchgate.net
Purpose Preoperative aromatase inhibitor (AI) treatment promotes breast-conserving
surgery (BCS) for estrogen receptor (ER)–positive breast cancer. To study this treatment …
surgery (BCS) for estrogen receptor (ER)–positive breast cancer. To study this treatment …
Randomized phase II neoadjuvant comparison between letrozole, anastrozole, and exemestane for postmenopausal women with estrogen receptor-rich stage 2 to 3 …
MJ Ellis, VJ Suman, J Hoog, L Lin… - Journal of Clinical …, 2011 - mayoclinic.elsevierpure.com
Purpose: Preoperative aromatase inhibitor (AI) treatment promotes breast-conserving
surgery (BCS) for estrogen receptor (ER)-positive breast cancer. To study this treatment …
surgery (BCS) for estrogen receptor (ER)-positive breast cancer. To study this treatment …
[引用][C] Randomized Phase II Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women With Estrogen Receptor-Rich …
MJ ELLIS, VJ SUMAN, LJ ESSERMAN… - Journal of clinical …, 2011 - pascal-francis.inist.fr
Author ELLIS, Matthew J; SUMAN, Vera J; ESSERMAN, Laura J; UNZEITIG, Gary W;
MARGENTHALER, Julie; BABIERA, Gildy V; KELLY MARCOM, P; GUENTHER, Joseph M; …
MARGENTHALER, Julie; BABIERA, Gildy V; KELLY MARCOM, P; GUENTHER, Joseph M; …
Randomized Phase II Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women With Estrogen Receptor–Rich Stage 2 …
MJ Ellis, VJ Suman, J Hoog, L Lin, J Snider… - Journal of Clinical …, 2011 - cir.nii.ac.jp
< jats: sec>< jats: title> Purpose</jats: title>< jats: p> Preoperative aromatase inhibitor (AI)
treatment promotes breast-conserving surgery (BCS) for estrogen receptor (ER)–positive …
treatment promotes breast-conserving surgery (BCS) for estrogen receptor (ER)–positive …
Randomized phase II neoadjuvant comparison between letrozole, anastrozole, and exemestane for postmenopausal women with estrogen receptor-rich stage 2 to 3 …
MJ Ellis, VJ Suman, J Hoog, L Lin… - Journal of Clinical …, 2011 - profiles.wustl.edu
Purpose: Preoperative aromatase inhibitor (AI) treatment promotes breast-conserving
surgery (BCS) for estrogen receptor (ER)-positive breast cancer. To study this treatment …
surgery (BCS) for estrogen receptor (ER)-positive breast cancer. To study this treatment …